Literature DB >> 3597679

Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study.

P E Leaverton, P D Sorlie, J C Kleinman, A L Dannenberg, L Ingster-Moore, W B Kannel, J C Cornoni-Huntley.   

Abstract

The Framingham Heart Study has been the foundation upon which several national policies regarding risk factors for coronary heart disease mortality are based. The NHANES I Epidemiologic Followup Study is the first national cohort study based upon a comprehensive medical examination of a probability sample of United States adults. The average follow-up time was 10 years. This study afforded an opportunity to evaluate the generalizability of the Framingham risk model, using systolic blood pressure, total cholesterol, and cigarette smoking, to the U.S. population with respect to predicting death from coronary heart disease. The Framingham model predicts remarkably well for this national sample. The major risk factors for coronary heart disease mortality described in previous Framingham analyses are applicable to the United States white adult population.

Entities:  

Mesh:

Year:  1987        PMID: 3597679     DOI: 10.1016/0021-9681(87)90129-9

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  30 in total

Review 1.  What is the optimal age for starting lipid lowering treatment? A mathematical model.

Authors:  S Ulrich; A D Hingorani; J Martin; P Vallance
Journal:  BMJ       Date:  2000-04-22

2.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.

Authors:  I U Haq; L E Ramsay; W W Yeo; P R Jackson; E J Wallis
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

3.  Cardiovascular risk factors in Mexican American adults: a transcultural analysis of NHANES III, 1988-1994.

Authors:  J Sundquist; M A Winkleby
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

4.  The validity of health risk appraisals for coronary heart disease: results from a randomized field trial.

Authors:  K W Smith; S M McKinlay; J B McKinlay
Journal:  Am J Public Health       Date:  1991-04       Impact factor: 9.308

Review 5.  Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study.

Authors:  William B Kannel; Philip A Wolf
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

Review 6.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

7.  Take Heart II: replication of a worksite health promotion trial.

Authors:  R E Glasgow; J R Terborg; L A Strycker; S M Boles; J F Hollis
Journal:  J Behav Med       Date:  1997-04

Review 8.  Uses and abuses of multivariate methods in epidemiology.

Authors:  S J Evans
Journal:  J Epidemiol Community Health       Date:  1988-12       Impact factor: 3.710

9.  Association between Framingham risk score and subclinical atherosclerosis among elderly with both type 2 diabetes mellitus and healthy subjects.

Authors:  Moatassem S Amer; Mohamed S Khater; Omar H Omar; Randa A Mabrouk; Shimaa A Mostafa
Journal:  Am J Cardiovasc Dis       Date:  2014-01-15

10.  Aspirin for primary prevention of cardiovascular events.

Authors:  F A Augustovski; S B Cantor; C T Thach; S J Spann
Journal:  J Gen Intern Med       Date:  1998-12       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.